Oragenics, Inc.
USD0.58
-0.01 (-1.59%)
CEO
Janet Huffman
IPO Date
2004-02-25
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
US
Open
$0.60
Prev. Close
$0.59
Day Low
$0.58
Day High
$0.60
52W Low
$0.50
52W High
$1.80
Market Cap
$0.00B
Volume
0.05M
| -6.9 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -652.0% | -415.9% | 0.10 | 2.15 | -18.4 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -109.8% | -96.8% | 0.05 | 8.95 | -26.6 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -59.3% | -55.7% | 0.03 | 19.17 | -96.2 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -156.9% | -141.5% | 0.05 | 13.40 | -28.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -90.4% | -78.8% | 0.06 | 10.18 | -42.6 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | -47.5% | -45.0% | 0.01 | 18.79 | -33.9 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | -106.6% | -93.3% | 0.01 | 8.01 | -51.6 |
| 31 Dec 2016 | FY | 0.0% | 0.0% | -236.5% | -162.8% | 0.02 | 3.14 | -103.0 |
| -0.4 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -31.2% | -24.1% | 0.04 | 4.42 | -0.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | 106.8% | -106.2% | -1.41 | 0.71 | -0.0 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -1610.2% | -57.3% | 18.55 | 1.04 | -0.4 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | 1580.6% | -227.4% | -1.55 | 0.87 | -5.5 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -80.0% | -47.3% | 0.17 | 1.93 | -7.6 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -173.8% | -85.1% | 0.00 | 1.17 | -15.6 |
| 31 Mar 2024 | Q1 | 0.0% | 0.0% | -93.4% | -69.4% | 0.05 | 2.69 | -15.3 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -402.4% | -256.7% | 0.10 | 2.15 | -8.6 |